As of 2026-03-15, the Relative Valuation of Moderna Inc (MRNA) is (102.57) USD. This relative valuation is based on P/E multiples. With the latest stock price at 52.56 USD, the upside of Moderna Inc based on Relative Valuation is -295.2%.
The range of the Relative Valuation is (116.44) - (106.47) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.3x - 14.7x | 12.0x |
| Forward P/E multiples | 16.1x - 17.0x | 16.4x |
| Fair Price | (116.44) - (106.47) | (102.57) |
| Upside | -321.5% - -302.6% | -295.2% |
| Date | P/E |
| 2026-03-13 | -7.28 |
| 2026-03-12 | -7.39 |
| 2026-03-11 | -7.75 |
| 2026-03-10 | -7.61 |
| 2026-03-09 | -7.72 |
| 2026-03-06 | -7.27 |
| 2026-03-05 | -7.45 |
| 2026-03-04 | -8.00 |
| 2026-03-03 | -6.90 |
| 2026-03-02 | -7.32 |
| 2026-02-27 | -7.42 |
| 2026-02-26 | -7.16 |
| 2026-02-25 | -7.11 |
| 2026-02-24 | -6.99 |
| 2026-02-23 | -6.96 |
| 2026-02-20 | -6.90 |
| 2026-02-19 | -6.88 |
| 2026-02-18 | -6.45 |
| 2026-02-17 | -6.08 |
| 2026-02-13 | -5.85 |
| 2026-02-12 | -5.55 |
| 2026-02-11 | -5.61 |
| 2026-02-10 | -5.81 |
| 2026-02-09 | -5.81 |
| 2026-02-06 | -5.68 |
| 2026-02-05 | -5.66 |
| 2026-02-04 | -5.92 |
| 2026-02-03 | -5.84 |
| 2026-02-02 | -5.89 |
| 2026-01-30 | -6.10 |
| 2026-01-29 | -6.49 |
| 2026-01-28 | -6.27 |
| 2026-01-27 | -6.29 |
| 2026-01-26 | -6.64 |
| 2026-01-23 | -6.74 |
| 2026-01-22 | -7.18 |
| 2026-01-21 | -6.90 |
| 2026-01-20 | -5.95 |
| 2026-01-16 | -5.79 |
| 2026-01-15 | -5.45 |
| 2026-01-14 | -5.62 |
| 2026-01-13 | -5.48 |
| 2026-01-12 | -4.68 |
| 2026-01-09 | -4.75 |
| 2026-01-08 | -4.69 |
| 2026-01-07 | -4.97 |
| 2026-01-06 | -4.94 |
| 2026-01-05 | -4.45 |
| 2026-01-02 | -4.27 |
| 2025-12-31 | -4.08 |